Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)
CNY 46.57
(-0.04%)
CNY 46.57
(-0.04%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 22.81 Billion CNY | 7.26% |
| 2022 | 21.27 Billion CNY | -17.87% |
| 2021 | 25.9 Billion CNY | -6.59% |
| 2020 | 27.73 Billion CNY | 19.09% |
| 2019 | 23.28 Billion CNY | 33.7% |
| 2018 | 17.41 Billion CNY | 25.89% |
| 2017 | 13.83 Billion CNY | 24.72% |
| 2016 | 11.09 Billion CNY | 19.08% |
| 2015 | 9.31 Billion CNY | 25.01% |
| 2014 | 7.45 Billion CNY | 20.14% |
| 2013 | 6.2 Billion CNY | 14.13% |
| 2012 | 5.43 Billion CNY | 19.44% |
| 2011 | 4.55 Billion CNY | 21.53% |
| 2010 | 3.74 Billion CNY | 23.61% |
| 2009 | 3.02 Billion CNY | 26.6% |
| 2008 | 2.39 Billion CNY | 22.09% |
| 2007 | 1.95 Billion CNY | 37.77% |
| 2006 | 1.42 Billion CNY | 20.62% |
| 2005 | 1.17 Billion CNY | 2.98% |
| 2004 | 1.14 Billion CNY | 9.02% |
| 2003 | 1.05 Billion CNY | 38.93% |
| 2002 | 756.02 Million CNY | 19.2% |
| 2001 | 634.26 Million CNY | 30.86% |
| 2000 | 484.7 Million CNY | 17.1% |
| 1999 | 413.92 Million CNY | 13.78% |
| 1998 | 363.79 Million CNY | 19.84% |
| 1997 | 303.57 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 5.99 Billion CNY | 3.3% |
| 2024 Q3 | 6.58 Billion CNY | -12.69% |
| 2024 Q2 | 7.54 Billion CNY | 25.82% |
| 2023 Q1 | 5.49 Billion CNY | 3.05% |
| 2023 Q4 | 5.8 Billion CNY | -0.67% |
| 2023 Q2 | 5.67 Billion CNY | 3.35% |
| 2023 Q3 | 5.84 Billion CNY | 2.98% |
| 2023 FY | 22.81 Billion CNY | 7.26% |
| 2022 Q2 | 4.74 Billion CNY | -13.31% |
| 2022 Q1 | 5.47 Billion CNY | -4.0% |
| 2022 Q4 | 5.32 Billion CNY | -6.77% |
| 2022 FY | 21.27 Billion CNY | -17.87% |
| 2022 Q3 | 5.71 Billion CNY | 20.38% |
| 2021 Q3 | 6.9 Billion CNY | 8.37% |
| 2021 Q2 | 6.36 Billion CNY | -8.09% |
| 2021 FY | 25.9 Billion CNY | -6.59% |
| 2021 Q1 | 6.92 Billion CNY | -16.73% |
| 2021 Q4 | 5.7 Billion CNY | -17.31% |
| 2020 FY | 27.73 Billion CNY | 19.09% |
| 2020 Q1 | 5.52 Billion CNY | -12.87% |
| 2020 Q2 | 5.78 Billion CNY | 4.61% |
| 2020 Q3 | 8.1 Billion CNY | 40.17% |
| 2020 Q4 | 8.32 Billion CNY | 2.68% |
| 2019 Q1 | 4.96 Billion CNY | 0.16% |
| 2019 FY | 23.28 Billion CNY | 33.7% |
| 2019 Q2 | 5.05 Billion CNY | 1.86% |
| 2019 Q3 | 6.91 Billion CNY | 36.75% |
| 2019 Q4 | 6.34 Billion CNY | -8.31% |
| 2018 Q2 | 3.9 Billion CNY | 1.21% |
| 2018 Q3 | 4.69 Billion CNY | 20.35% |
| 2018 FY | 17.41 Billion CNY | 25.89% |
| 2018 Q1 | 3.85 Billion CNY | 2.32% |
| 2018 Q4 | 4.95 Billion CNY | 5.56% |
| 2017 Q3 | 3.72 Billion CNY | 17.2% |
| 2017 Q1 | 3.16 Billion CNY | 12.01% |
| 2017 Q4 | 3.76 Billion CNY | 1.29% |
| 2017 Q2 | 3.17 Billion CNY | 0.19% |
| 2017 FY | 13.83 Billion CNY | 24.72% |
| 2016 Q4 | 2.82 Billion CNY | -5.2% |
| 2016 Q1 | 2.66 Billion CNY | 9.14% |
| 2016 Q3 | 2.98 Billion CNY | 14.34% |
| 2016 FY | 11.09 Billion CNY | 19.08% |
| 2016 Q2 | 2.61 Billion CNY | -2.18% |
| 2015 Q1 | 2.2 Billion CNY | 12.3% |
| 2015 Q4 | 2.44 Billion CNY | -1.59% |
| 2015 Q3 | 2.48 Billion CNY | 13.86% |
| 2015 Q2 | 2.18 Billion CNY | -0.98% |
| 2015 FY | 9.31 Billion CNY | 25.01% |
| 2014 Q1 | 1.72 Billion CNY | 3.33% |
| 2014 FY | 7.45 Billion CNY | 20.14% |
| 2014 Q4 | 1.96 Billion CNY | -0.84% |
| 2014 Q3 | 1.97 Billion CNY | 10.63% |
| 2014 Q2 | 1.78 Billion CNY | 3.93% |
| 2013 Q3 | 1.56 Billion CNY | 5.42% |
| 2013 Q2 | 1.48 Billion CNY | 0.37% |
| 2013 FY | 6.2 Billion CNY | 14.13% |
| 2013 Q1 | 1.48 Billion CNY | 6.19% |
| 2013 Q4 | 1.66 Billion CNY | 6.25% |
| 2012 Q4 | 1.39 Billion CNY | -2.34% |
| 2012 Q1 | 1.33 Billion CNY | 8.84% |
| 2012 Q2 | 1.27 Billion CNY | -5.17% |
| 2012 Q3 | 1.42 Billion CNY | 12.44% |
| 2012 FY | 5.43 Billion CNY | 19.44% |
| 2011 Q3 | 1.15 Billion CNY | 10.02% |
| 2011 Q4 | 1.23 Billion CNY | 6.83% |
| 2011 Q2 | 1.04 Billion CNY | -6.41% |
| 2011 FY | 4.55 Billion CNY | 21.53% |
| 2011 Q1 | 1.11 Billion CNY | 20.33% |
| 2010 Q4 | 930.07 Million CNY | -1.54% |
| 2010 Q1 | 942.47 Million CNY | 15.29% |
| 2010 Q2 | 926.92 Million CNY | -1.65% |
| 2010 Q3 | 944.62 Million CNY | 1.91% |
| 2010 FY | 3.74 Billion CNY | 23.61% |
| 2009 Q4 | 817.49 Million CNY | 4.49% |
| 2009 FY | 3.02 Billion CNY | 26.6% |
| 2009 Q2 | 717.58 Million CNY | 0.85% |
| 2009 Q1 | 711.56 Million CNY | 17.56% |
| 2009 Q3 | 782.32 Million CNY | 9.02% |
| 2008 Q4 | 605.26 Million CNY | 2.62% |
| 2008 Q3 | 589.81 Million CNY | -1.53% |
| 2008 Q2 | 598.98 Million CNY | 0.08% |
| 2008 Q1 | 598.49 Million CNY | 4.53% |
| 2008 FY | 2.39 Billion CNY | 22.09% |
| 2007 Q2 | 498.23 Million CNY | 23.97% |
| 2007 Q4 | 572.54 Million CNY | 17.57% |
| 2007 Q3 | 486.96 Million CNY | -2.26% |
| 2007 Q1 | 401.91 Million CNY | 4.93% |
| 2007 FY | 1.95 Billion CNY | 37.77% |
| 2006 Q2 | 337.37 Million CNY | 1.17% |
| 2006 Q1 | 333.48 Million CNY | 10.36% |
| 2006 Q4 | 383.03 Million CNY | 3.93% |
| 2006 FY | 1.42 Billion CNY | 20.62% |
| 2006 Q3 | 368.56 Million CNY | 9.25% |
| 2005 Q1 | 290.45 Million CNY | 14.64% |
| 2005 Q2 | 287.7 Million CNY | -0.94% |
| 2005 Q3 | 298.92 Million CNY | 3.9% |
| 2005 Q4 | 302.17 Million CNY | 1.09% |
| 2005 FY | 1.17 Billion CNY | 2.98% |
| 2004 Q2 | 269.46 Million CNY | 9.94% |
| 2004 FY | 1.14 Billion CNY | 9.02% |
| 2004 Q4 | 253.35 Million CNY | -32.83% |
| 2004 Q1 | 245.11 Million CNY | -15.32% |
| 2004 Q3 | 377.21 Million CNY | 39.99% |
| 2003 Q1 | 222.77 Million CNY | 6.53% |
| 2003 Q3 | 264.85 Million CNY | -3.07% |
| 2003 FY | 1.05 Billion CNY | 38.93% |
| 2003 Q4 | 289.47 Million CNY | 9.29% |
| 2003 Q2 | 273.24 Million CNY | 22.66% |
| 2002 Q4 | 209.11 Million CNY | 10.86% |
| 2002 Q2 | 209.97 Million CNY | 41.59% |
| 2002 Q1 | 148.3 Million CNY | 0.0% |
| 2002 FY | 756.02 Million CNY | 19.2% |
| 2002 Q3 | 188.63 Million CNY | -10.17% |
| 2001 FY | 634.26 Million CNY | 30.86% |
| 2000 FY | 484.7 Million CNY | 17.1% |
| 1999 FY | 413.92 Million CNY | 13.78% |
| 1998 FY | 363.79 Million CNY | 19.84% |
| 1997 FY | 303.57 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 10.05 Billion CNY | -126.871% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 6.73 Billion CNY | -238.935% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 2.31 Billion CNY | -887.069% |
| Aurora Optoelectronics Co.,Ltd. | 327.9 Million CNY | -6859.193% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 121.77 Million CNY | -18638.758% |
| NanJing Pharmaceutical Company Limited | 53.58 Billion CNY | 57.418% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 1.28 Billion CNY | -1677.22% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 3.07 Billion CNY | -642.006% |